PHRM.L Regulatory News (PHRM)

20 Dec 2007 17:47

Phorm Inc20 December 2007 20 December 2007 Phorm, Inc. ("Phorm" or the "Company") Grant of Options The Company (AIM: PHRM and PHRX) announces that, on 19 December 2007, thefollowing share options were granted to Directors: Kent Ertugrul, Chief Executive Officer, was granted options to acquire 250,000common shares in the Company at a price of £18.05 per share. Virasb Vahidi, Chief Operating Officer, was granted options to acquire 100,000common shares in the Company at a price of £18.05 per share. The term of the options is a 10 year period based on certain vesting performancemilestones regarding the progress of the Company's business to be satisfied by31 December 2008 and 30 June 2009 or such later dates as set by the RemunerationCommittee of the Company. Virasb Vahidi has also been granted additional options to acquire 25,000 commonshares in the Company at a price of £18.05 per share. The term of these 25,000options is for ten years and they vest immediately. For Enquiries Phorm, Inc. +44 870 405 7722Kent Ertugrul (Chairman & Chief Executive) Citigate Dewe Rogerson +44 20 7638 9571Simon RigbyJustin Griffiths Canaccord Adams Limited +44 20 7050 6500Nominated AdviserMark WilliamsAndrew Chubb This information is provided by RNS The company news service from the London Stock Exchange